Neoplasms

Digestive System Diseases

All Conditions

Rectal Neoplasms

Colorectal Neoplasms

Intestinal Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Gastrointestinal Diseases

Intestinal Diseases

Rectal Diseases

Robotic assisted transanal total mesorectal excision for rectal cancer patients

Laparoscopic transanal total mesorectal excision for rectal cancer patients

Robotic assisted transanal total mesorectal excision

Laparoscopic assisted transanal total mesorectal excision for rectal cancer patients

Laparoscopic assisted transanal total mesorectal excision

Weidong Tong, MD

Total mesorectal excision has greatly reduced the local recurrence rate of rectal cancer after colorectal surgery. Transanal total mesorectal excision(TaTME) is potentially a suitable option for patients with middle and low rectal cancer. Robotic systems are expected to develop the advantages of TaTME to overcome the limitations of laparoscopic surgery. This study aimed to investigate the safety and feasibility of robotic assisted transanal total mesorectal excision in patients with rectal cancer.

TaTME is potentially a suitable option for patients with middle or low rectal cancer, especially for males with obesity and a narrow pelvis.The da Vinci robotic system (Intuitive Surgical, Sunnyvale, CA, USA) is expected to overcome the limitations of the laparoscopic transanal approach for rectal surgery. Da Vinci Si Surgical System or da Vinci Xi Surgical System would be used to performed Transanal total mesorectal excision. And the surgery would performed by two-team approach. This study aimed to investigate the safety and feasibility of robotic assisted transanal total mesorectal excision in patients with rectal cancer.

Safety and Feasibility Study of Robotic Assisted Transanal Total Mesorectal Excision for Rectal Cancer

The incidence of local recurrence rectal cancer within two years after surgery

The incidence of postoperative anastomotic leakage within 30 days after surgery

The 5-year survival rates of rectal cancer

The incidence of distant metastasis rectal cancer within two years after surgery

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Safety and Feasibility Study of Robotic Assisted Transanal Total Mesorectal Excision for Rectal Cancer	NCT04573738	Rectal Cancer Perioperative C...	Robotic assiste... Laparoscopic as...	18 Years - 80 Years	Third Military Medical University
Safety and Feasibility Study of Robotic Assisted Transanal Total Mesorectal Excision for Rectal Cancer	NCT04573738	Rectal Cancer Perioperative C...	Robotic assiste... Laparoscopic as...	18 Years - 80 Years	Third Military Medical University
Safety and Feasibility Study of Robotic Assisted Transanal Total Mesorectal Excision for Rectal Cancer	NCT04573738	Rectal Cancer Perioperative C...	Robotic assiste... Laparoscopic as...	18 Years - 80 Years	Third Military Medical University

Spots Global Cancer Trial Database for robotic assisted transanal total mesorectal excision